Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term: media
2009
PHARMAC documents that matched your search:
Prescriptions for medicine keep rising but rate slowing
(2 pages, 114 KB)
2009/12/08
8 December 2009 Media release Prescriptions for medicine keep rising but rate slowing, says PHARMAC Prescriptions for government funded medicines increased by almost 4 percent last year to 36.3 million, but the rate of that growth is slowing, drug buying…
Promoting competition continuing to pay dividends
(2 pages, 81 KB)
2009/12/08
8 December 2009 Media release Promoting competition continuing to pay dividends, says PHARMAC Promoting competition through its purchasing strategies is continuing to provide long-term benefits, according to Government medicine funder PHARMAC. In its Annual Review, published today, PHARMAC Funding and…
Newly-funded antidepressant to meet unmet need – PHARMAC
(1 page, 67 KB)
2009/11/12
31 October 2009 Media release Newly-funded antidepressant to meet unmet need – PHARMAC An antidepressant that will be funded from 1 November will help meet an unmet need for people with severe depression, says PHARMAC’s medical director Dr Peter Moodie.…
PHARMAC pays tribute to health professionals’ role in brand changes
(2 pages, 109 KB)
2009/10/29
29 October 2009 Media release PHARMAC pays tribute to health professionals’ role in brand changes PHARMAC is acknowledging the role health professionals played in implementing medicine brand changes that affected a very large number of New Zealanders during 2008/09. Highlights…
PHARMAC looking to improve consumer participation
(2 pages, 73 KB)
2009/10/13
12 October 2009 Media release PHARMAC looking to improve consumer participation Government medicine funder PHARMAC is asking for feedback on options for improving its consumer participation. PHARMAC has issued a discussion document that puts forward seven options for improving consumer…
New medicines, savings result from agreement
(2 pages, 106 KB)
2009/10/12
1 October 2009 Media release New medicines, savings result from agreement New funded treatments for HIV/AIDS and nausea, and a strengthened osteoporosis treatment have emerged from an agreement between PHARMAC and pharmaceutical company Merck Sharp & Dohme (MSD). The agreement…
Heart drug deals to save $65 million
(2 pages, 76 KB)
2009/09/07
7 September 2009 Media release Heart drug deals to save $65 million PHARMAC has completed agreements with two companies for the heart drug metoprolol that will realise $65 million of savings over the next five years. Metoprolol, a beta-blocker, is…
Disabling cardiovascular disease gets funded treatments
(1 page, 64 KB)
2009/08/11
19 June 2009 Media release Disabling cardiovascular disease gets funded treatments People with a rare but disabling cardiovascular condition will have easier and more consistent access to three funded medicines following a decision by PHARMAC. Pulmonary arterial hypertension (PAH) is…
New leukaemia treatment funded
(1 page, 70 KB)
2009/08/03
Media release, 3 August 2009 New leukaemia treatment funded PHARMAC is funding a new medication for patients with chronic myeloid leukaemia, called dasatanib (Sprycel). Chronic myeloid leukaemia (CML) is relatively rare with about 40 new cases diagnosed in New Zealand…
Adalimumab access widening
(2 pages, 68 KB)
2009/07/31
Media release Embargoed to 00:01 Saturday 1 August 2009 `Biologic’ drug funding takes treatment out of hospitals People with a number of painful and disabling inflammatory conditions will avoid hospital visits for treatment following a funding decision by PHARMAC. The…
